Cargando…
Predicted outcomes of subdividing M1-stage metastatic lung cancer based on the prognosis and the response to local consolidative therapy
BACKGROUND: For stage IV non-small cell lung cancer (NSCLC) patients, systemic therapy is the main strategy, and local consolidative therapy tends to be performed for patients with oligometastases. The porpose of this article is to evaluate the prognostic effects of local consolidative therapy for p...
Autores principales: | Wang, Fang, Gao, Jiani, Ren, Yijiu, Su, Hang, She, Yunlang, Xie, Dong, Chen, Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422121/ https://www.ncbi.nlm.nih.gov/pubmed/34532430 http://dx.doi.org/10.21037/atm-21-1383 |
Ejemplares similares
-
A new method for predicting survival in stage I non-small cell lung cancer patients: nomogram based on macrophage immunoscore, TNM stage and lymphocyte-to-monocyte ratio
por: Gao, Jiani, et al.
Publicado: (2020) -
Prognostic Analysis of Limited Resection Versus Lobectomy in Stage IA Small Cell Lung Cancer Patients Based on the Surveillance, Epidemiology, and End Results Registry Database
por: Gu, Chang, et al.
Publicado: (2018) -
Is operation safe for lung cancer patients with interstitial lung disease on computed tomography?
por: Tang, Hai, et al.
Publicado: (2020) -
Staging of ovarian cancer: time to subdivide more?
por: Denny, Lynette
Publicado: (2013) -
Bayesian network meta-analysis of efficacy and safety of neoadjuvant therapy for non-small-cell lung cancer
por: Ren, Yijiu, et al.
Publicado: (2020)